key: cord-0951561-ytn9bvkb authors: Barut, Tuba; Halwe, Nico Joel; Taddeo, Adriano; Kelly, Jenna N.; Schön, Jacob; Ebert, Nadine; Ulrich, Lorenz; Devisme, Christelle; Steiner, Silvio; Trüeb, Bettina Salome; Hoffmann, Bernd; Veiga, Inês Berenguer; Leborgne, Nathan Georges François; Moreira, Etori Aguiar; Breithaupt, Angele; Wylezich, Claudia; Höper, Dirk; Wernike, Kerstin; Godel, Aurélie; Thomann, Lisa; Flück, Vera; Stalder, Hanspeter; Brügger, Melanie; Esteves, Blandina I. Oliveira; Zumkehr, Beatrice; Beilleau, Guillaume; Kratzel, Annika; Schmied, Kimberly; Ochsenbein, Sarah; Lang, Reto M.; Wider, Manon; Machahua, Carlos; Dorn, Patrick; Marti, Thomas M.; Funke-Chambour, Manuela; Rauch, Andri; Widera, Marek; Ciesek, Sandra; Dijkman, Ronald; Hoffmann, Donata; Alves, Marco P.; Benarafa, Charaf; Beer, Martin; Thiel, Volker title: The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype date: 2022-04-28 journal: bioRxiv DOI: 10.1101/2022.04.28.489537 sha: 3d1947029455dde21a72bc2a548c1da5c5bedbcc doc_id: 951561 cord_uid: ytn9bvkb Variant of concern (VOC) Omicron-BA1 has achieved global predominance in early 2022. Therefore, surveillance and comprehensive characterization of Omicron-BA.1 in advanced primary cell culture systems and multiple animal models is urgently needed. Here, we characterized Omicron-BA.1 and recombinant Omicron-BA.1 spike gene mutants in comparison with VOC Delta in well-differentiated primary human nasal and bronchial epithelial cells in vitro, followed by in vivo fitness characterization in naïve hamsters, ferrets and hACE2-expressing mice, and in immunized hACE2-mice. We demonstrate a spike-mediated enhancement of early replication of Omicron-BA.1 in nasal epithelial cultures, but limited replication in bronchial epithelial cultures. In Syrian hamsters, Delta showed dominance over Omicron-BA.1 and in ferrets, Omicron-BA.1 infection was abortive. In mice expressing the authentic hACE2-receptor, Delta and a Delta spike clone also showed dominance over Omicron-BA.1 and an Omicron-BA.1 spike clone, respectively. Interestingly, in naïve K18-hACE2 mice, we observed Delta spike-mediated increased replication and pathogenicity and Omicron-BA.1 spike-mediated reduced replication and pathogenicity, suggesting that the spike gene is a major determinant of both Delta and Omicron-BA.1 replication and pathogenicity. Finally, the Omicron-BA.1 spike clone was less well controlled by mRNA-vaccination in K18-hACE2-mice and became more competitive compared to the progenitor and Delta spike clones, suggesting that spike gene-mediated immune evasion is another important factor that led to Omicron-BA.1 dominance. To evaluate individual VOC fitness advantages in direct competition with the precursing 159 VOC, we then turned to animal models with natural susceptibility towards SARS-CoV-2: 160 ferrets and Syrian hamsters. Donor animals were simultaneously co-inoculated with two 161 VOCs at iso-titer and transmission to contact animals was investigated (Extended Data Fig. 162 2a,b). 163 We investigated fitness of the VOC Delta in competition with Alpha after intranasal co-164 inoculation of 10 4.625 TCID 50 of an Alpha-Delta mixture at a 1.95:1 ratio (Extended Data Fig. 165 2a, 5). For all donor and contact hamsters, Alpha showed complete dominance in nasal 166 washings and respiratory tissues (Extended Data Fig. 5, 8) . The animals showed signs of 167 severe disease and 10 of 12 contact hamsters reached the humane endpoint, (defined by a 20% 168 loss of the initial body weight) (Extended Data Fig. 3a, c, 5) . While Alpha was clearly dominant in all animals, sera equally neutralized Alpha and Delta VOCs (VNT 100 ) (Extended 170 Data Fig. 7a ). 171 We also tested Delta vs Omicron-BA.1 (total 10 4.5 TCID 50 at a 1:2.16 ratio) in hamsters (Fig. 172 2a, Extended Data Fig. 2a) . Upon inoculation or contact, all animals lost body weight, 173 however, only one animal was euthanized after reaching the humane endpoint for body 174 weight loss (Fig. 2a, Extended Data Fig. 3b, d) . Although starting with a clear advantage for 175 Omicron-BA.1 in the inoculum, Delta was immediately prevalent in nasal washings of donor 176 hamsters with up to 10 8 genome copies per mL (GE/mL) (Fig. 2a) . Remarkably, despite high 177 genome loads of Delta, Omicron-BA.1 still replicated to 10 7 GE/mL (Fig. 2a) . Nevertheless, 178 Delta was preferentially transmitted as seen in both nasal washings and organ samples of 179 contact animals (Fig. 2a, Extended Data Fig. 4 ). In tissues of donor animals at 4 dpi, mainly 180 Delta was found in the upper (URT) and lower respiratory tract (LRT) (Fig. 2b) ; with highest 181 Delta loads in the nasal concha (10 8 GE/mL). However, Omicron-BA.1 was still present in the 182 URT of each donor animal (up to 10 7 GE/mL) (Fig. 2b) . Consequently, the antibody response 183 was mainly directed against Delta with neutralization up to a serum dilution of 1:1024, while 184 Omicron-BA.1 was only barely neutralized (Fig. 2d ). Together, we show that the Syrian 185 hamster is highly susceptible also for the SARS-CoV-2 VOCs Alpha, Delta, and BA.1. However, the Alpha VOC seems to be best replicating and transmitting in the Syrian 187 hamster model associated with the highest fatality rates. washing for up to 10 days, with highest viral genome loads of up to more than 10 7 GE/mL at 195 5 and 6 dpi (Fig. 2f) . Two out of three contact animals were infected by 6 days post contact 196 (dpc) and viral loads in contacts reached up to 10 8 GE/mL (Fig. 2f) . These results were also 197 confirmed by serology (Fig. 2f) . 198 Next, ferrets were co-inoculated with VOCs Alpha and Delta (1.33:1 ratio, 10 5 TCID 50 in 199 total) (Extended Data Fig. 2b, 6 ). All ferrets remained clinically healthy throughout the 200 animal experiment and did not lose body weight (Extended Data Fig. 3g) . Within 3 days, 201 Delta fully outcompeted Alpha in both replication and transmission (Extended Data Fig. 6 ), 202 which is in line with the epidemiological situation observed in humans. These observations 203 were further supported by the matching serological data (Extended Data Fig. 7b ). 204 We finally investigated competition of Delta and Omicron-BA.1 in the ferret model by 205 inoculating a 10 4.75 TCID 50 Delta-Omicron mixture (1:1.43 ratio) (Fig. 2c, Extended Data Fig. 206 2B). All ferrets remained clinically healthy throughout the animal experiment and did not lose 207 body weight (Extended Data Fig. 3h ). Astonishingly, only Delta was detected in all nasal 208 washings of the donor ferrets, starting at 1 dpi at levels of up to 10 7 GE/mL (Fig. 2c) . In 209 addition, 5 out of 6 contact ferrets showed shedding of Delta (highest loads: 10 7 GE/mL), Table 1 ). In a 235 competition setting, Delta also dominated over in the URT and LRT (Fig. 3f, 236 Extended Data Fig. 9b ). To determine the importance of the spike mutations, hACE2-KI mice 237 were inoculated with an equivalent mixture of recombinant clones only differing by the spike 238 sequence, SARS-CoV-2 S-Delta and SARS-CoV-2 S-Omicron . As for the VOC isolates, SARS-239 CoV-2 S-Delta fully dominated over SARS-CoV-2 S-Omicron in the URT and LRT of hACE2-KI 240 mice indicating that the spike is of major importance for the phenotype of both VOCs and that 241 spike mutations do not provide an advantage to Omicron-BA.1 over Delta in a humanized 242 mouse model (Fig. 3g) . These findings suggest that the intrinsic replicative properties of 243 Omicron-BA.1 are unlikely the decisive factor for the observed replacement of Delta by 244 Omicron-BA.1 in the human population. Interestingly, only unvaccinated mice inoculated with SARS-CoV-2 S-Delta , or SARS-CoV-260 2 D614G showed reduction in body weight at 6 dpi, while unvaccinated mice challenged with 261 SARS-CoV-2 S-Omicron and all vaccinated mice, regardless of the challenge virus, did not lose 262 body weight (Fig. 4b) . Accordingly, clinical scores were highest for unvaccinated mice 263 infected with SARS-CoV-2 S-Delta (Extended Data Fig. 10b ). Viral RNA loads in 264 oropharyngeal swabs and several organs were mostly lower for SARS-CoV-2 S-Omicron -infected 265 mice and remained high for SARS-CoV-2 S-Delta in the nasal cavity (Fig. 4c) . Nevertheless, 266 viral RNA loads were in most cases reduced at 6 dpi in vaccinated mice, although, as 267 expected, reduction was less pronounced in SARS-CoV-2 S-Delta -and SARS-CoV-2 S-Omicron -268 infected mice (Fig. 4c) . Strikingly, the detection of infectious virus in the nose, lung and brain 269 of infected naïve and vaccinated mice perfectly illustrated the effect of vaccination and 270 phenotypic differences between SARS-CoV-2 D614G , SARS-CoV-2 S-Delta and SARS-CoV-2 S-271 Omicron (Fig. 4d) . Infectious wild-type SARS-CoV-2 D614G is detected in unvaccinated mice in 272 the nose and lung and later at 6 dpi at lower levels also in the brain. However, mRNA 273 immunization efficiently restricted SARS-CoV-2 D614G replication, as infectious virus was only 274 detectable at 2 dpi in the nose and not in any other tissue. SARS-CoV-2 S-Delta titers in 275 unvaccinated mice were comparable to SARS-CoV-2 D614G titers in the nose, while we 276 observed higher titers in the lung and particularly in the brain (Fig. 4d, Extended Data Fig. 277 10d,e). As expected, SARS-CoV-2 S-Delta showed some degree of immune escape as infectious 278 virus was readily detectable at 2 dpi in the nose and lung, but eventually was cleared at 6 dpi 279 in vaccinated mice (Fig. 4d) . Finally, we detected less infectious virus of SARS-CoV-2 S-280 Omicron compared to SARS-CoV-2 D614G and SARS-CoV-2 S-Delta in the nose, lung and brain of 281 unvaccinated mice, suggesting that the Omicron-BA.1 spike gene confers a less virulent 282 phenotype than the 614G and the Delta spike gene (Fig. 4d , Extended Data Fig. 10d ,e). Moreover, the Omicron-BA.1 spike gene conferred the largest degree of immune evasion, 284 since infectious titers were comparable between vaccinated and unvaccinated mice in the nose 285 at 2 and 6 dpi and in the lung at 2 dpi. However, no infectious virus was detected in the brains 286 of vaccinated mice, and titers in the lungs were reduced compared to unvaccinated mice at 6 287 dpi, suggesting that the mRNA vaccine is still of advantage to combat SARS-CoV-2 S-Omicron Table 2 ). Unvaccinated 291 mice infected with SARS-CoV-2 S-Delta displayed severe interstitial lymphohistiocytic 292 pneumonia with concurrent vascular inflammation and widespread nucleocapsid antigen 293 detection in the immunohistochemical (IHC) analysis starting already at 2 dpi, while infection 294 with SARS-CoV-2 D614G resulted in similarly severe pathological findings only at 6 dpi. In 295 contrast, unvaccinated mice that were infected with SARS-CoV-2 S-Omicron displayed milder 296 histopathological lung lesions and less nucleocapsid antigen was detected by IHC analysis. In 297 agreement with the observed reduced virus titers in the lungs of vaccinated mice, we observed 298 milder lung histopathological lesions and almost no nucleocapsid antigen IHC detection in 299 vaccinated mice with any of the viruses when compared to lungs of unvaccinated mice. Collectively, these findings demonstrate the major impact of the Delta and Omicron-BA.1 301 spike genes on virus replication, immune evasion, and pathogenicity. Compared to the 302 progenitor D614G spike gene, the Delta spike gene confers increased replication, 303 pathogenicity, and immune escape. The Omicron-BA.1 spike gene is conferring the greatest 304 degree of immune evasion, compared to the wild-type D614G spike and the Delta spike 305 genes, resulting in comparable or even increased detection of infectious SARS-CoV-2 S-Omicron 306 compared to SARS-CoV-2 D614G and SARS-CoV-2 S-Delta , in several tissues and organs of 307 vaccinated mice. Importantly, the Omicron-BA.1 spike gene also confers reduced 308 pathogenicity, as seen in unvaccinated mice (Fig. 4b,e) , suggesting that the Omicron-BA.1 309 spike is a major determinant of the observed milder disease in humans. The appearance of Omicron-BA.1 in the human population exemplified a remarkable jump in 313 SARS-CoV-2 evolution. Omicron-BA.1 has acquired up to 50 mutations of which at least 34 314 are located within the spike gene 3 . Particularly, the NTD and RBD harbor many mutations 315 that have not been seen in previous SARS-CoV-2 variants, suggesting substantial changes in 316 spike antigenicity, receptor binding, and possibly other spike functions. Accordingly, the 317 current experimental systems to assess phenotypic changes of SARS-CoV-2 require a revision 318 regarding the extent to which they truly reflect epidemiological and clinical observations in 319 humans. We and others previously showed that the Syrian hamster is a highly susceptible 320 animal model for several SARS-CoV-2 variants and showed a great efficiency in replication 321 and transmission 9, 10, 13 Delta in humans and that it will receive further attention in future studies that aim at assessing 356 SARS-CoV-2 variants with high pathogenicity. Notably, by using hNEC and hBEC cultures we were able to detect an accelerated growth of In summary, we provide here a comprehensive and comparative analysis of the Omicron-380 BA.1 phenotype by using several advanced in vitro and in vivo systems and different VOCs. 381 We demonstrate that Omicron-BA.1 displays a remarkable evolutionary and phenotypic jump 382 that impacts virus replication, host and tissue tropism, pathogenicity, and immune escape, 383 with the spike gene being a key determinant of these phenotypic changes. Authors declare that they have no competing interests. Tukey"s multiple-comparison test; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. e-g) 490 NECs, BECs, or lung explants were infected with virus mixtures at a 1:1 ratio based on determined using two-way ANOVA (a-d) and P values were adjusted using Tukey"s 567 multiple-comparison test; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Data were 568 obtained from one experiment. Each data point represents one biological replicate. "artic gupplex" was used to filter "pass" reads based on length with --max-length set to 1400. The "artic minion" command was then used to align the filtered reads to the Wuhan- viruses in the mixture, non-lineage-defining mutations, sites that were difficult to call (e.g., Hamster competition studies 787 The study outline for the hamster competition studies can be seen in Extended Data Figure 2a . intranasally with 20 μl per nostril with the virus inoculum described in the results section. Euthanasia and organ collection was performed 2 or 6 dpi as described above. All mice were monitored daily for body weight loss and clinical signs. Oropharyngeal swabs 860 were collected daily as described before 10 . hACE2-KI mice (7 to 19 week-old female, n=6/group) were intranasally inoculated with 10 4 1132 TCID 50 of a 1:1 mix of Delta and Omicron or SARS-CoV-2 S-Delta and SARS-CoV-2 S-Omicron . The graph on the left shows the body weight loss for each of the inoculated animal. The graph 1134 on the right shows the histopathological score in these mice. Data are mean ± s.d. from the 1135 indicated number of biological replicates from a single experiment. applies to c, d, e and f. Statistical significance was determined using two-way ANOVA (a-d) 1153 and P values were adjusted using Tukey"s multiple-comparison test; *P < 0.05, **P < 0.01, 1154 ***P < 0.001, ****P < 0.0001. Data were obtained from one experiment. Each data point 1155 represents one biological replicate. Extended Data Table 1 : List of viruses used in this study. A67V del69-70 T95I del142-144 Y145D del211 L212I ins214EPE G339D S371L S373P S375F K417N N440K G446S S477N E484A Q493R G496S Q498R N501Y Y505H T547K H655Y N679K P681H N764K D796Y N856K Q954H N969K L981F ORF3 Donor Contact e f g h Extended Data Figure 4 Concha Extended Data Figure 5 Extended Data Figure 6 Antibody escape and global spread of SARS-CoV-2 lineage A Rapid reconstruction of SARS-CoV-2 using a synthetic 992 genomics platform Lethal infection of K18-hACE2 mice infected with severe 995 acute respiratory syndrome coronavirus Multi-species ELISA for the detection of antibodies against SARS-998 CoV-2 in animals Pulmonary mesenchymal stem cells are engaged in distinct steps of 1001 host response to respiratory syncytial virus infection SARS-CoV-2 can infect and propagate in human placenta explants Improvements to the ARTIC multiplex PCR method for SARS-1008 K18 mice SARS-CoV-2 D614G Single SARS-CoV-2 D614G Single SARS-CoV-2 D614G vs Delta SARS-CoV-2 D614G vs SARS-CoV-2 D614G vs SARS-CoV-2 S-Delta SARS-CoV-2 D614G vs SARS-CoV-2 S-Omicron Alpha EPI_ISL_751799 Hamster and ferret Delta Single SARS-CoV-2 D614G vs Delta Delta vs Omicron-BA Delta vs SARS-CoV-2 S-Delta Delta Single Delta vs Omicron-BA Single Delta vs Omicron-BA Single SARS-CoV-2 D614G vs Omicron-BA SARS-CoV-2 S-Delta Will be provided 241 2832 3037 5386 6512 8393 10029 10449 11282 11537 13195 14408 15240 21762 21764 21846 21986 22193 22204 22578 22673 22679 22686 22813 22882 22898 22992 22995 23013 23040 23048 23055 23063 23075 23202 23525 23599 23854 23948 24130 24424 24469 24503 25000 25584 26270 26530 26577 27259 27807 28311 28361 28881 241 2832 3037 5386 6512 8393 10029 10449 11282 11537 13195 14408 15240 21762 21764 21846 21986 22193 22204 22578 22673 22679 22686 22813 22882 22898 22992 22995 23013 23040 23048 23055 23063 23075 23202 23525 23599 23854 23948 24130 24424 24469 24503 25000 25584 26270 26530 26577 27259 27807 28311 28361